170 related articles for article (PubMed ID: 37816875)
1. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
[TBL] [Abstract][Full Text] [Related]
2. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
3. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
Tsien C; Shah SN; McCullough AJ; Dasarathy S
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):85-93. PubMed ID: 23011041
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Improvement of Sarcopenia after Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhotic Patients.
Huang S; Liu J; Cai J; Zhou C; Wang Y; Yang C; Li T; Chen Y; Ju S; Wang C; Yao W; Bai Y; Xiong B
J Vasc Interv Radiol; 2023 Apr; 34(4):639-644. PubMed ID: 36586464
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
[TBL] [Abstract][Full Text] [Related]
7. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
[TBL] [Abstract][Full Text] [Related]
8. Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis.
Zhang Q; Long L; Zhu HL; Peng H; Luo XH; Zhu KS; Wang RP
World J Gastroenterol; 2023 Nov; 29(42):5768-5780. PubMed ID: 38075849
[TBL] [Abstract][Full Text] [Related]
9. Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.
Bai YW; Liu JC; Yang CT; Wang YL; Wang CY; Ju SG; Zhou C; Huang SJ; Li TQ; Chen Y; Yao W; Xiong B
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):948-955. PubMed ID: 35594511
[TBL] [Abstract][Full Text] [Related]
10. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
Liu J; Ma J; Yang C; Chen M; Shi Q; Zhou C; Huang S; Chen Y; Wang Y; Li T; Xiong B
Radiology; 2022 Jun; 303(3):711-719. PubMed ID: 35289658
[TBL] [Abstract][Full Text] [Related]
12. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
[TBL] [Abstract][Full Text] [Related]
14. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
15. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
Praktiknjo M; Book M; Luetkens J; Pohlmann A; Meyer C; Thomas D; Jansen C; Feist A; Chang J; Grimm J; Lehmann J; Strassburg CP; Abraldes JG; Kukuk G; Trebicka J
Hepatology; 2018 Mar; 67(3):1014-1026. PubMed ID: 29059469
[TBL] [Abstract][Full Text] [Related]
16. Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis.
Wu CH; Ho MC; Kao JH; Ho CM; Su TH; Hsu SJ; Huang HY; Lin CY; Liang PC
J Formos Med Assoc; 2023 Aug; 122(8):747-756. PubMed ID: 36868900
[TBL] [Abstract][Full Text] [Related]
17. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.
Jahangiri Y; Pathak P; Tomozawa Y; Li L; Schlansky BL; Farsad K
J Vasc Interv Radiol; 2019 Jun; 30(6):866-872.e4. PubMed ID: 31053265
[TBL] [Abstract][Full Text] [Related]
18. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
Song J; Wang X; Yan Y; Xiang T; Luo X
Dig Dis Sci; 2023 Jul; 68(7):3185-3192. PubMed ID: 36715817
[TBL] [Abstract][Full Text] [Related]
19. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
Song J; Wang X; Yan Y; Xiang T; Luo X
Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
